JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 32 No. 2 242-244
© 1991 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patrick, S. T.
Right arrow Articles by Wolfangel, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patrick, S. T.
Right arrow Articles by Wolfangel, R. G.

Comparison of In Vitro RBC Labeling with the UltraTag® RBC Kit Versus In Vivo Labeling

Shawn T. Patrick, Jerry V. Glowniak, Fredrick E. Turner, Mark S. Robbins and Robert G. Wolfangel

Veterans Administration Medical Center, Portland, Oregon
Mallinckrodt Medical, Inc., St. Louis, Missouri

Correspondence: For reprints contact: Jerry V. Glowniak, MD, VA Medical Center, P.O. Box 1034, Portland, OR 97207.

ABSTRACT

This study compared cardiac-gated equilibrium blood-pool imaging studies using in vitro technetium-99m- (99mTc) labeled red blood cells (ABCs) prepared with the UltraTag® RBC kit to in vivo labeling with stannous (pyro- and trimeta-) phosphates. The in vitro labeling procedure takes ~ 25 min and does not require centrifugation to separate free from bound 99mTc. Imaging studies were performed in 30 patients using the in vitro labeling procedure and in 30 patients with in vivo labeling. Regions of interest were placed over the center of the left ventricle, inferior and lateral to the left ventricle (background), and over the right midlung. The mean ± s.e. in vitro RBC labeling efficiency was 98.5 ± 0.2%. The heart-to-background ratios were significantly higher with in vitro labeling. The heart-to-background ratios, averaged among two blinded reviewers, were 4.6 and 3.4 for the in vitro and in vivo methods, respectively. The heart-to-lung ratio was generally higher with the in vitro procedure (3.6) than that observed with the in vivo method (3.2) but failed to attain statistical significance (p = 0.059). These results demonstrate the superiority of the in vitro labeling procedure over in vivo labeling for gated equilibrium blood-pool imaging.




This article has been cited by other articles:


Home page
J. Nucl. Med. Technol.Home page
A. Meyers, J. M. Durski, and A. A. Snow
Nuclear Medicine Gastrointestinal Bleeding Examination Utilizing an UltraTag Kit Reveals Unusual Bone Marrow and Hepatic Uptake: A Case Study Report
J. Nucl. Med. Technol., March 1, 2004; 32(1): 16 - 18.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1991 by the Society of Nuclear Medicine.